17417 Risk factors and impact of conversion to an indeterminate interferon-gamma release assay result in patients receiving biologics.

Title

17417 Risk factors and impact of conversion to an indeterminate interferon-gamma release assay result in patients receiving biologics.

Creator

Khanna U; Ellis A; Saklecha A; Gallop J; Galadari A; Sun L; Fernandez AP

Publisher

Journal Of The American Academy Of Dermatology

Date

2020
2020-12-02

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Format

journalArticle

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Pages

AB82-AB82

Volume

83

ISSN

0190-9622

NEOMED College

NEOMED College of Medicine Student

NEOMED Department

NEOMED Student Publications

Update Year & Number

December 2020 List

Citation

Khanna U; Ellis A; Saklecha A; Gallop J; Galadari A; Sun L; Fernandez AP, “17417 Risk factors and impact of conversion to an indeterminate interferon-gamma release assay result in patients receiving biologics.,” NEOMED Bibliography Database, accessed May 10, 2024, https://neomed.omeka.net/items/show/11481.